title: Bacteriology testing of cardiovascular tissues: comparison of transport solution versus tissue testing.
abstract: Bacteriology testing is mandatory for quality control of recovered cardiovascular allografts (CVA). In this paper, two different bacteriology examinations (A tests) performed before tissue antibiotic decontamination were compared: transport solution filtration analysis (A1) and tissue fragment direct incubation (A2). For this purpose, 521 CVA (326 heart and 195 artery tissues) from 280 donors were collected and analyzed by the European Homograft Bank (EHB). Transport solution (A1) tested positive in 43.25 % of hearts and in 48.21 % of arteries, whereas the tissue samples (A2) tested positive in 38.34 % of hearts and 33.85 % of arteries. The main species identified in both A1 and A2 were Staphylococcus spp. in 55 and 26 % of cases, and Propionibacterium spp. in 8 and 19 %, respectively. Mismatches in bacteriology results between both initial tests A1 and A2 were found. 18.40 % of the heart valves were identified as positive by A1 whilst 13.50 % were considered positive by A2. For arteries, 20.51 % of cases were positive in A1 and negative in A2, and just 6.15 % of artery allografts presented contamination in the A2 test but were considered negative for the A1 test. Comparison between each A test with the B and C tests after antibiotic treatment of the allograft was also performed. A total decontamination rate of 70.8 % of initial positive A tests was obtained. Due to the described mismatches and different bacteria identification percentage, utilization of both A tests should be implemented in tissue banks in order to avoid false negatives.
authors.affiliation: Saint Jean Clinique, European Homograft Bank, Rue du Méridien 100, 1210, Brussels, Belgium. rdiaz@clstjean.be.
authors.forename: R
authors.initials: R
authors.lastname: Díaz Rodríguez
authors.affiliation: Saint Jean Clinique, European Homograft Bank, Rue du Méridien 100, 1210, Brussels, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Van Hoeck
authors.affiliation: Saint Jean Clinique, European Homograft Bank, Rue du Méridien 100, 1210, Brussels, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Mujaj
authors.affiliation: Saint Jean Clinique, European Homograft Bank, Rue du Méridien 100, 1210, Brussels, Belgium.
authors.forename: R
authors.initials: R
authors.lastname: Ngakam
authors.affiliation: Saint Jean Clinique, European Homograft Bank, Rue du Méridien 100, 1210, Brussels, Belgium.
authors.forename: Y
authors.initials: Y
authors.lastname: Fan
authors.affiliation: I-BioStat, KU Leuven - University of Leuven, Louvain, Belgium.|I-BioStat, Universiteit Hasselt, Hasselt, Belgium.
authors.forename: K
authors.initials: K
authors.lastname: Bogaerts
authors.affiliation: Saint Jean Clinique, European Homograft Bank, Rue du Méridien 100, 1210, Brussels, Belgium.
authors.forename: R
authors.initials: R
authors.lastname: Jashari
mesh_terms: D001431:Bacteriological Techniques / Q000379:methods*; D002319:Cardiovascular System / Q000187:drug effects / Q000382:microbiology*; D003451:Cryoprotective Agents / Q000494:pharmacology*; D006801:Humans; D014186:Transportation
chemical_list: D003451:Cryoprotective Agents
keywords: Cardiovascular allografts; Comparison of bacteriology tests; False negatives; Mismatches